Welcome to our dedicated page for Flotek Inds Del SEC filings (Ticker: FTK), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Flotek Industries鈥� SEC disclosures can feel like a chemistry textbook mixed with an engineering manual鈥攈undreds of pages on green stimulation fluids, down-hole tools, and JP3 analytics. If you have ever asked, 鈥淗ow do I locate chemical segment margins in the Flotek Industries annual report 10-K simplified?鈥� or searched for 鈥淔lotek Industries insider trading Form 4 transactions,鈥� this page ends the hunt.
Stock Titan鈥檚 AI decodes every filing the moment it hits EDGAR. Whether you need the latest 鈥淔lotek Industries quarterly earnings report 10-Q filing鈥� or want 鈥淔lotek Industries 8-K material events explained,鈥� our platform translates legalese into plain language, tags key numbers, and links them to historical trends. AG真人官方-time alerts flag 鈥淔lotek Industries Form 4 insider transactions real-time,鈥� so you can monitor executive moves between chemical contract announcements.
Here鈥檚 what you can do:
- Scan AI-powered summaries that answer, 鈥渦nderstanding Flotek Industries SEC documents with AI鈥� in minutes.
- Drill into 鈥淔lotek Industries proxy statement executive compensation鈥� to see how ESG targets impact bonuses.
- Track 鈥淔lotek Industries executive stock transactions Form 4鈥� alongside segment revenue from the same quarter.
- Download red-lined comparisons between filings for faster 鈥淔lotek Industries earnings report filing analysis.鈥�
From production-boosting chemistry details to board-level pay structures, every Form 10-K, 10-Q, 8-K, and S-4 lives here鈥攃ontinuously updated, clearly summarized, and always searchable. Complex documents, simplified insights.
Form 4 filing overview
On July 8, 2025 Agios Pharmaceuticals, Inc. (AGIO) granted Director Jay T. Backstrom two equity awards:
- 23,393 non-qualified stock options at an exercise price of $36.28, vesting 25 % after one year and monthly thereafter through July 2029; expiration July 8, 2035.
- 4,341 restricted stock units (RSUs) convertible into one share each, vesting in three equal annual tranches starting July 8, 2026.
After the grant, Backstrom beneficially owns 23,393 options and 4,341 RSUs, all held directly.
The transaction is coded 鈥淎,鈥� indicating a company-issued award rather than an open-market purchase, and no shares were sold. No financial performance metrics or strategic disclosures are included, making this a routine compensation event that modestly aligns the director鈥檚 incentives with shareholder interests.
Flotek Industries, Inc. (FTK) has filed a Form S-8 to register an additional 900,000 shares of common stock for issuance under its 2018 Long-Term Incentive Plan, as amended. Following this filing, the total number of shares registered for the plan will rise to 3,316,667. The amendment was approved by shareholders at the May 16, 2025 annual meeting. Standard exhibits鈥攊ncluding the plan document, legal opinion, auditor consent, and filing-fee table鈥攁re attached. No financial results, transactions, or operational updates are included; the filing is exclusively administrative and pertains to employee equity compensation.
Ocugen, Inc. (NASDAQ: OCGN) has filed a Form 144 indicating a planned insider sale. The notice covers the potential disposition of 112,205 common shares鈥攁产辞耻迟 0.04 % of the 292.0 million shares outstanding鈥攖丑谤辞耻驳丑 Morgan Stanley Smith Barney LLC. The aggregate market value of the planned sale is $122,886.92, implying a reference price near $1.10 per share. The seller acquired the shares on 07/09/2025 via stock-option exercise and intends to sell on or after the same date on the NASDAQ exchange. No other sales were reported in the past three months. By signing the form, the filer asserts there is no undisclosed material adverse information regarding Ocugen.
The filing signals a modest insider liquidity event rather than a strategic transaction; the size is immaterial relative to float and should have limited market impact under normal trading volumes.
FAQ
What is the current stock price of Flotek Inds Del (FTK)?
What is the market cap of Flotek Inds Del (FTK)?
What are the core business segments of Flotek Industries?
How does Flotek integrate technology into its offerings?
What makes Flotek's specialty chemicals unique?
How does the Data Analytics segment add value to customers?
Who are the primary customers of Flotek Industries?
How does Flotek sustain its competitive advantage?
What role does sustainability play in Flotek's operations?
How does Flotek ensure the reliability of its measurement systems?
